This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Fast food makes the immune system more ... The immune system reacts similarly to a high fat and high ... (17 Jan 2018)
Cycling does not damage men’s sexual or ... New study in The Journal of Urology® finds that cardiovascular ... (17 Jan 2018)
Estrogen-mimicking compounds in foods may ... New TSRI study suggests breast cancer patients taking ... (17 Jan 2018)
Prolonged periods of sedentary time strongly ... A team of researchers from the NIHR Leicester Biomedical ... (16 Jan 2018)
A more complete Mediterranean diet may ... New study in The Journal of Urology® finds that a high intake of ... (17 Jan 2018)
Monday, 11 December 2017 21:32

Postmenopausal breast cancer: It is sufficient to extend treatment by two years Featured

Rate this item
(0 votes)

Standard treatment for postmenopausal breast cancer is to give a hormonal breast cancer drug for 5 years following surgical removal of the tumour.

The results of the recent study (ABCSG 16/S.A.L.S.A) conducted by the Austrian Breast & Colorectal Cancer Study Group (ABCSG) now show that two years of follow-on treatment with the aromatase inhibitor anastrozole is sufficient. Further extension of treatment to five years is not helpful, because it does not improve the treatment outcome but can worsen side effects. The study was presented to the San Antonio Breast Cancer Symposium (SABCS).

Anti-hormone therapy suppresses the female sex hormones oestrogen and/or progesterone, since they can stimulate the growth of hormone-receptor-positive tumours and thus lead to relapse (recurrence). Earlier studies suggested that extended endocrine therapy has a positive impact upon disease-free survival but the question of the optimum length of treatment has hitherto remained unanswered. ABCSG 16/S.A.L.S.A has now tested this important clinical question.

Seven or ten years of endocrine therapy?

A total of 3,484 postmenopausal breast cancer patients at more than 70 Austrian centres took part in the investigation between 2004 and 2010 – making it one of the largest clinical studies so far conducted in Austria. The participants had an early hormone-receptor-positive breast cancer (Stage I-III) and, after 5 years of standard adjuvant anti-hormone therapy (endocrine therapy) they received an additional 2 or 5 years of the aromatase inhibitor anastrozole by way of extended endocrine therapy. "We discovered that two years on an aromatase inhibitor following endocrine therapy are sufficient and that prolonging the treatment offers no benefit but increases side effects," says Michael Gnant, coordinating investigator for the study.

Clear results

Anastrozole blockades oestrogen synthesis, thereby preventing recurrence but has a different mode of action and a more favourable toxicity profile than tamoxifen, which has been used for many years. It has now been demonstrated in this and similarly designed international studies that patients do not benefit from extending endocrine therapy to five years but they do suffer more side effects, such as fractures. There is therefore no indication for a total treatment time of 10 years. Studies also show that patient compliance diminishes with longer treatment. "Up until now, we were unable to say whether there is a subgroup of patients that might benefit from extended treatment. We hope that the new molecular testing methods, which we are currently trialling, can bring more clarity in this respect," says Gnant, with an eye to the future.


 


Source: Medical University of Vienna

Read 184 times Last modified on Tuesday, 12 December 2017 13:09

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

  • Free Clinic Rooms Available

    Pharmasal, a chain of 6 retail pharmacies has a number of free clinic rooms available within the pharmacies in Tarxien, St. Paul’s Bay, Zejtun, and Dingli. We are looking to increase our list of family doctors and specialists. Family doctors are given preference for the clinic at Zejtun.  For more information, please send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. or call on 99425939.

    Written on October 18, 2017
  • AVAILABLE CLINICS

    Rational Pharmacy, Valley Road, B'Kara requires consultants & family doctors for early morning & afternoon sessions.

    Please contact 99891732 or This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.

    Written on October 09, 2017

SPONSOR MESSAGE

No data displayed on the module. Please check some parameters in the module settings again!

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…